-
Covidien Announces Organizational Changes; Bryan C. Hanson will become Group President
Wednesday, June 15, 2011 - 8:07am | 184Covidien (NYSE: COV) today announced several leadership changes that will streamline its organization to accelerate growth and innovation. These changes are all effective July 1, 2011. Bryan C. Hanson will become Group President, with responsibility for the Surgical Devices and Energy-based...
-
Masimo Announces Rainbow Agreement with Philips
Wednesday, June 15, 2011 - 8:01am | 55Masimo (NASDAQ: MASI) today announced that it has reached a long-term non-exclusive agreement under which Philips will integrate Masimo rainbow SET technology into Philips' products. Masimo expects to begin diligent co-development projects with Philips, which should allow rainbow SET technology...
-
Oppenheimer Maintains Outperform on Mindray Medical Int'l
Wednesday, June 15, 2011 - 7:19am | 73Oppenheimer is out with its report today on Mindray Medical Int'l (NYSE: MR), maintaining Outperform. In a note to clients, Oppenheimer writes, "Management kept >16% top-line guidance unchanged assuming a 17-18% growth rate in China. We tweak our model slightly to reflect potential 2012 margin...
-
IVAX Diagnostics Confirms That Its Policy is Not to Comment on Unusual Market Activity
Tuesday, June 14, 2011 - 1:44pm | 54IVAX Diagnostics, Inc. (NYSE: IVD) today reported that, in light of the unusual market activity in its stock, the NYSE Amex contacted IVAX Diagnostics in accordance with the NYSE Amex's usual practice. IVAX Diagnostics confirmed that its policy is not to comment on unusual market activity.
-
Options Brief: Covidien Public Limited Company
Tuesday, June 14, 2011 - 10:26am | 78Shares of Covidien Public Limited Company (NYSE: COV) are higher on the session by 0.82%, trading at $53.88. Overall call volume is now running at 7.07x the daily average, with 1% of all calls traded being purchases on the offer. 8,287 contracts have traded on the session so far. Covidien Public...
-
UPDATE: Wedbush Downgrades AngioDynamics to Underperform
Tuesday, June 14, 2011 - 9:10am | 129Wedbush is out with its report today on AngioDynamics (NASDAQ: ANGO), downgrading ANGO to Underperform. In a note to clients, Wedbush writes, "It is a very tough operating environment, and the outlook for ANGO's performance has recently gotten a lot cloudier. With a management transition now...
-
Gabelli Downgrades AngioDynamics To Sell
Tuesday, June 14, 2011 - 8:54am | 18Gabelli has downgraded AngioDynamics (NASDAQ: ANGO) from Hold to Sell.
-
Jefferies Reports on NXTM's Strong Growth
Tuesday, June 14, 2011 - 8:50am | 91According to a recent report from Jefferies, the growth on NxStage Medical (NASDAQ: NXTM) remains very good and although there are some concerns over the company's decision to approach CMS to get more reimbursement, Jefferies believes that NXTM is approaching CMS from a position of strength and not...
-
Benzinga's Top Downgrades
Tuesday, June 14, 2011 - 8:24am | 138Analysts at Goldman Sachs downgraded SunPower Corporation (NASDAQ: SPWRA) from “neutral” to “sell.” SPWRA's shares closed at $21.27 yesterday. SunPower's trailing-twelve-month profit margin is 7.06%. Analysts at Needham downgraded Gerber Scientific Inc (NYSE: GRB) from “buy” to “hold.” GRB's...
-
Wedbush Downgrades AngioDynamics To Underperform, Lowers PT To $12
Tuesday, June 14, 2011 - 7:56am | 27Wedbush Securities has downgraded AngioDynamics (NASDAQ: ANGO) from Neutral to Underperform and has lowered the price target from $14 to $12.
-
Citi Reiterates Hold on Integra Lifesciences Holdings
Tuesday, June 14, 2011 - 7:43am | 130Citi reiterated its Hold rating on Integra Lifesciences Holdings (NASDAQ: IART) after a meeting with the company's management. In a research report published today, Citi states, "With expectations of 5-7% rev growth and low to mid single digit EPS growth, 2011 is an investment year. Beyond 2011...
-
Stocks to Watch for 6/14/11: Fresh 52-Week Highs and Lows
Tuesday, June 14, 2011 - 4:15am | 2234The following stocks hit new 52-week highs in Monday's trading session: 1) Greif (NYSE: GEF): Shares of Greif hit a 52-week high of $67.36 in Monday's trading session. The stock closed at $67.04. The year-to-date performance of Greif has been a gain of 9%. 2) Raptor Pharmaceutical (NASDAQ: RPTP...
-
Build a Wealthy Portfolio with These Economic Moats
Tuesday, June 14, 2011 - 1:33am | 1474Warren Buffett mentions moats all the time in his talks and writings and emphasizes the importance of finding a company with moats. The thing is, I haven't come across anything specific from Buffett where he explains how to distinguish and categorize moats but The Little Book That Builds Wealth...
-
Huge Dividend Increases are a Sign of an Economic Turnaround
Monday, June 13, 2011 - 11:20pm | 480What better indication of a company's health than an increase in dividend. And if lots of companies raise their dividend across various sectors, it is a positive sign for the economy. If you own a high yield stock for the long term for its income, and the stock increases its dividend, then you...
-
Health Care Sector Showing Strength
Monday, June 13, 2011 - 1:28pm | 382The Health Care Sector is the strongest area of the market in today's trading session, currently up 0.5% on the day. The best performing stocks in the S&P 500 Health Care Sector currently are: 1) Forest Laboratories (NYSE: FRX): Shares of Forest Laboratories are currently trading up 1.8% from...